New research reveals that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight people often shed about a fifth of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month after stopping.
"Users buying such treatments need to be cognizant of the potential of quick weight regain when the medication is stopped," cautioned researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to original mass within about 18 months.
Analyzing Approaches
The study, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.
Scientists emphasize that people who shed pounds through lifestyle changes alone usually see a more gradual weight regain—approximately 100 grams monthly—once they finish.
Understanding the Rapid Rebound
Doctors propose the way of the injections explains the accelerated rebound.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of GLP-1 levels several times higher than normal could lead to the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making overeating much more probable."
A Lifelong Condition?
The NHS suggest the injections for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, due to the high risk of weight regain, the treatment should be considered life-long.
This opinion is echoed by pharmaceutical companies, who say that the results "emphasize the persistent nature of obesity," similar to managing diseases like high blood pressure.
User Accounts
Users who have come off the jabs report a intense resurgence of hunger.
"It felt as if a switch activating and you become extremely hungry," described one woman.
The struggle is worsened if patients have not adopted lasting lifestyle or habit modifications during treatment.
Significant Use
Figures indicate that millions of people in the UK have used these injections in the last 12 months, with demand remaining high.
- Use is more common among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, clinicians stress that while GLP-1 drugs are effective tools for weight loss, they are not a magic solution and lasting health benefits likely depends on ongoing behavioural management.
